NAGE
Niagen Bioscience
$2.54
+$0.04 (+1.6%)Oct 28, 2026
Key metrics
The numbers that frame NAGE today
- Market cap
- $200.98M
- P/E (TTM)
- 14.1
- EV / FCF
- 24.1
- Gross margin
- 64.2%
- EV / Sales
- 1.1
- ROIC
- 88.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.39
- 52wk High
- $7.95
Growth
Revenue and earnings trend for NAGE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NAGE
Is Niagen Bioscience a good buy?
No. Niagen Bioscience has mixed quality and poor momentum. The setup is weak overall. Growth looks weak. That could put pressure on the long-term business case. We think Niagen Bioscience is selling at a low price, but price alone does not change the weak overall picture.
What is the market capitalization of NAGE?
Niagen Bioscience's market capitalization is $200.98M.
What is the P/E (TTM) ratio for NAGE stock?
Niagen Bioscience's P/E (TTM) ratio is 14.1, based on trailing earnings.
What is the 52-week high for NAGE stock?
The 52-week high for Niagen Bioscience is $7.95. The current close of $2.54 is 68.1% below that high.
What is the 52-week low for NAGE stock?
The 52-week low for Niagen Bioscience is $2.39. The current close of $2.54 is 6.5% above that low.
Does NAGE stock pay dividends?
Niagen Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NAGE?
Niagen Bioscience's Debt / Equity ratio is 0.03.